Envol Biomedical
Christopher Kosman has a diverse work experience in the field of pharmacology and toxicology. Christopher started their career at Merck as a Scientist in 1999 and worked there until 2003. Christopher then joined Encysive Pharmaceuticals as a Principal Scientist III in drug development from 2004 to 2006. After that, Christopher founded their own company, Safety Pharmacology Consulting, LLC, in 2008, where they worked as a Founder and consultant until 2015. In 2007, they briefly worked as a Study Director at Ricerca Bioscience. From 2016 to 2018, Christopher worked as a Safety Pharmacologist at Sinclair Research Center, LLC. Currently, they hold the position of V.P. Pharmacology and Toxicology at Envol Biomedical since 2019.
Christopher Kosman has a Master of Science (MS) degree in toxicology from Thomas Jefferson University. Furthermore, they have pursued a field of study in regulatory pharmacology at the University of California, San Diego - School of Medicine. Additionally, Christopher holds a Doctor of Veterinary Medicine (DVM) degree in veterinary medicine from the University of Life Science.
This person is not in any teams
This person is not in any offices
Envol Biomedical
General Information: • Non-human primate preclinical research • Largest population available in the continental U.S. • On time delivery of study samples and study reports. • Supported by a dedicated software solution. • AAALAC accredited, USDA and OLAW compliant. Services and Capabilities: • Pharmacokinetics and ADME • Pharmacodynamics and biomarkers • Investigative and organ-specific toxicology • In vitro pharmacology and drug metabolism
Employees
51-200